Literature DB >> 15198545

Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.

Santos B Murty1, Jack Goodman, B C Thanoo, Patrick P DeLuca.   

Abstract

The purpose of this research was to study the chemical reactivity of a somatostatin analogue, octreotide acetate, formulated in microspheres with polymers of varying molecular weight and co-monomer ratio under in vitro testing conditions. Poly(D,L-lactide-co-glycolide) (PLGA) and poly(D,L-lactide) (PLA) microspheres were prepared by a solvent extraction/evaporation method. The microspheres were characterized for drug load, impurity content, and particle size. Further, the microspheres were subjected to in vitro release testing in acetate buffer (pH 4.0) and phosphate buffered saline (PBS) (pH 7.2). In acetate buffer, 3 microsphere batches composed of low molecular weight PLGA 50:50, PLGA 85:15, and PLA polymers (< or =10 kDa) showed 100% release with minimal impurity formation (<10%). The high molecular weight PLGA 50:50 microspheres (28 kDa) displayed only 70% cumulative release in acetate buffer with significant impurity formation (approximately 24%). In PBS (pH 7.4), on the other hand, only 50% release was observed with the same low molecular weight batches (PLGA 50:50, PLGA 85:15, and PLA) with higher percentages of hydrophobic impurity formation (ie, 40%, 26%, and 10%, respectively). In addition, in PBS, the high molecular weight PLGA 50:50 microspheres showed only 20% drug release with ~66% mean impurity content. The chemically modified peptide impurities inside microspheres were structurally confirmed through Fourier transform-mass spectrometry (FT-MS) and liquid chromatography/mass spectrometry (LC-MS/MS) analyses after extraction procedures. The adduct compounds were identified as covalently modified conjugates of octreotide with lactic and glycolic acid monomers within polymeric microspheres. The data suggest that due to steric hindrance factors, polymers with greater lactide content were less amenable to the formation of adduct impurities compared with PLGA 50:50 copolymers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15198545      PMCID: PMC2750643          DOI: 10.1208/pt040450

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

1.  Acylation of peptides by lactic acid solutions.

Authors:  Andrea Lucke; Achim Göpferich
Journal:  Eur J Pharm Biopharm       Date:  2003-01       Impact factor: 5.571

2.  Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

Authors:  R Jeyanthi; R C Mehta; B C Thanoo; P P DeLuca
Journal:  J Microencapsul       Date:  1997 Mar-Apr       Impact factor: 3.142

3.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

4.  Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion.

Authors:  S J Hunter; J A Shaw; K O Lee; P J Wood; A B Atkinson; J S Bevan
Journal:  Clin Endocrinol (Oxf)       Date:  1999-02       Impact factor: 3.478

5.  Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres.

Authors:  M J Blanco-Príeto; K Besseghir; P Orsolini; F Heimgartner; C Deuschel; H P Merkle; H Nam-Trân; B Gander
Journal:  Int J Pharm       Date:  1999-07-20       Impact factor: 5.875

6.  Formation of peptide impurities in polyester matrices during implant manufacturing.

Authors:  A Rothen-Weinhold; N Oudry; K Schwach-Abdellaoui; S Frutiger-Hughes; G J Hughes; D Jeannerat; U Burger; K Besseghir; R Gurny
Journal:  Eur J Pharm Biopharm       Date:  2000-05       Impact factor: 5.571

7.  A novel in vitro release technique for peptide containing biodegradable microspheres.

Authors:  J W Kostanski; P P DeLuca
Journal:  AAPS PharmSciTech       Date:  2000-03-09       Impact factor: 3.246

8.  Chemical interactions between drugs containing reactive amines with hydrolyzable insoluble biopolymers in aqueous solutions.

Authors:  A J Domb; L Turovsky; R Nudelman
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

  8 in total
  22 in total

1.  Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.

Authors:  Jae Hwa Ahn; Eun Ji Park; Hye Suk Lee; Kang Choon Lee; Dong Hee Na
Journal:  AAPS PharmSciTech       Date:  2011-09-21       Impact factor: 3.246

2.  In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes.

Authors:  Santos B Murty; Qui Wei; B C Thanoo; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2004-09-30       Impact factor: 3.246

3.  Effect of excipients on PLGA film degradation and the stability of an incorporated peptide.

Authors:  M L Houchin; S A Neuenswander; E M Topp
Journal:  J Control Release       Date:  2006-12-01       Impact factor: 9.776

4.  Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.

Authors:  Feng Qi; Liuqing Yang; Jie Wu; Guanghui Ma; Zhiguo Su
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

5.  Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.

Authors:  Ravi D Vaishya; Abhirup Mandal; Mitan Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-05-01       Impact factor: 5.875

6.  Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery.

Authors:  Stefano Giovagnoli; Paolo Blasi; Maurizio Ricci; Carlo Rossi
Journal:  AAPS PharmSciTech       Date:  2004-10-11       Impact factor: 3.246

7.  Proton Oriented-"Smart Depot" for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres.

Authors:  Jiwei Liu; Yan Xu; Yonglu Wang; Hao Ren; Zhengjie Meng; Kuntang Liu; Zhe Liu; He Huang; Xueming Li
Journal:  Pharm Res       Date:  2019-06-04       Impact factor: 4.200

8.  Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides.

Authors:  Sharad Kharel; Archana Gautam; Andreas Dickescheid; Say Chye Joachim Loo
Journal:  Pharm Res       Date:  2018-08-02       Impact factor: 4.200

9.  Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.

Authors:  Dong Hee Na; Santos B Murty; Kang Choon Lee; B C Thanoo; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003-12-31       Impact factor: 3.246

10.  Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.

Authors:  Ying Zhang; Andreas M Sophocleous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2009-06-16       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.